Quarterly report pursuant to Section 13 or 15(d)


6 Months Ended
Jun. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Liquidity [Text Block]
Note 2. Liquidity
The Company’s primary need for liquidity is to fund the working capital needs of the business and general corporate purposes. The Company has historically incurred losses and has relied on borrowings from members to fund the operations and growth of the business. As of June 30, 2019, the Company had cash of approximately
$1.3 million
working capital of approximately
 and an accumulated deficit of approximately
$9.7 million.
During 2018, the Company began to gain traction with more hospitals and witnessed customer renewals of expiring agreements with existing customers. During the first quarter of 2019, the Company signed four contracts with new customers and during the second quarter 
completed a number of data consulting projects as proof of concept for potentially new customers.
The Company’s target is to sign on average, a contract a month, with new customers during 2019. Management expects increases in revenue to provide sufficient cash flow to fund the operations for at least the one-year period following the release of these condensed consolidated financial statements.
On November 30,
2018, the Company completed a common stock private place of $1.25 million.
In February
2019, the transactions related to the purchase of Alliance MMA resulted in a gross increase of cash of $5.4
million which the Company has utilized a significant portion to operate the business. Management believes the remaining cash balance of $1.3 million along with anticipated increases in sales is expected to fund operations for at least the next 12 months; however, the Company will thereafter need to raise additional funding through strategic relationships, public or private equity or debt financings. If such funding is not available or not available on terms acceptable to the Company, the Company’s current plans for expansion, including new product development, may be curtailed or cancelled.